| Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches P Todke, VH Shah International Journal of Dermatology 57 (11), 1387-1402, 2018 | 23 | 2018 |
| Specialized tablets: Ancient history to modern developments A Advankar, R Maheshwari, V Tambe, P Todke, N Raval, D Kapoor, ... Drug delivery systems, 615-664, 2019 | 19 | 2019 |
| Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis PV Devarajan, P Dandekar, AA D'Souza Springer 39 (1), 2019 | 16 | 2019 |
| Micromeritics in pharmaceutical product development R Maheshwari, P Todke, K Kuche, N Raval, RK Tekade Dosage form design considerations, 599-635, 2018 | 16 | 2018 |
| Drug delivery systems RK Tekade Academic Press, 2019 | 15 | 2019 |
| Dosage Form Design Considerations: Volume I RK Tekade Academic Press, 2018 | 14 | 2018 |
| In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations PA Todke, PV Devarajan Journal of Controlled Release 349, 756-764, 2022 | 8 | 2022 |
| ‘Transfersome-embedded-gel’for dual-mechanistic delivery of anti-psoriatic drugs to dermal lymphocytes P Todke, S Polaka, N Raval, P Gondaliya, V Tambe, R Maheshwari, ... Journal of Microencapsulation 39 (6), 495-511, 2022 | 4 | 2022 |
| Stability and degradation studies for drug and drug product R Maheshwari, P Todke, N Soni, N Raval, PK Deb, B Amarji, ... Dosage Form Design Considerations, 225-257, 2018 | 4 | 2018 |
| CD Receptor and Targeting Strategies DJ Kotak, PA Todke, P Dandekar, PV Devarajan Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis, 383-406, 2019 | 1 | 2019 |
| Is receptor mediated active macrophage targeting of amphotericin B nanoformulations a promising approach? S Das, P Todke, M Madkaikar, P Devarajan RSC Pharmaceutics, 2024 | | 2024 |
